All Stories

  1. Role of Plasma Angiopoietin-1 and VEGF Levels as Potential Biomarkers in Chronic Central Serous Chorioretinopathy with Macular Neovascularization
  2. Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
  3. Circulating Anti-endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
  4. Updates in AERD: What is needed further?
  5. Comprehensive Analysis of Circular RNAs in Endothelial Cells
  6. Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study
  7. Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease
  8. Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD
  9. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis
  10. Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis
  11. Intravenous administration of Tat-NR2B9c peptide, a PSD95 inhibitor, attenuates reinstatement of cocaine-seeking behavior in rats
  12. Dynamic in vitro hemocompatibility of oligoproline self-assembled monolayer surfaces
  13. MiR-191 as a Key Molecule in Aneurysmal Aortic Remodeling
  14. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
  15. The NMDA Receptor Subunit (GluN1 and GluN2A) Modulation Following Different Conditions of Cocaine Abstinence in Rat Brain Structures
  16. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
  17. Endothelial cells response to neutrophil‐derived extracellular vesicles miRNAs in anti‐PR3 positive vasculitis
  18. miRNA Regulation of NK Cells Antiviral Response in Children With Severe and/or Recurrent Herpes Simplex Virus Infections
  19. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
  20. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study
  21. Design, Manufacturing Technology and In-Vitro Evaluation of Original, Polyurethane, Petal Valves for Application in Pulsating Ventricular Assist Devices
  22. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  23. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma
  24. Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
  25. Emerging role of non-coding RNAs in allergic disorders
  26. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs
  27. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  28. Association of Factor V Leiden With Subsequent Atherothrombotic Events
  29. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections
  30. Cocaine Self-Administration and Abstinence Modulate NMDA Receptor Subunits and Active Zone Proteins in the Rat Nucleus Accumbens
  31. Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy
  32. A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
  33. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium
  34. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
  35. Legends of Allergy/Immunology: Andrew Szczeklik
  36. Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort
  37. The interaction of laser radiation with tissue in the aspect of generating the process of decellularization in the preparation of animal origin autologous tissue
  38. Subphenotypes of NSAID‐exacerbated respiratory disease identified by latent class analysis
  39. Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration
  40. LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis
  41. IL-17–high asthma with features of a psoriasis immunophenotype
  42. Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins
  43. Cocaine-induced Changes in the Expression of NMDA Receptor Subunits
  44. Subtypes of eosinophilic asthma with discrete gene pathway phenotypes
  45. A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience
  46. Stratification of asthma phenotypes by airway proteomic signatures
  47. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease
  48. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
  49. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
  50. Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma
  51. Subsequent Event Risk in Individuals With Established Coronary Heart Disease
  52. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti‐inflammatory drug‐induced urticaria
  53. Stabilization of Synthetic Materials with Silver Particles
  54. Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin
  55. Molecular profiling of regulatory T cells in pulmonary sarcoidosis
  56. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
  57. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper
  58. Facilitated expansion of Th17 cells in lupus nephritis patients
  59. Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort
  60. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers
  61. U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes
  62. Eicosanoids and eosinophilic inflammation of airways in stable COPD.
  63. Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA
  64. Correction to: Fibroblast-to-myofibroblast transition in bronchial asthma
  65. Surface modification of metallic materials designed for a new generation of artificial heart valves
  66. Fibroblast-to-myofibroblast transition in bronchial asthma
  67. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome
  68. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis
  69. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma
  70. Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting
  71. Influence of TNF-α promoter variability on stage and grade in individuals with colorectal cancer
  72. miR-200b downregulates CFTR during hypoxia in human lung epithelial cells
  73. Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study
  74. Biomimetics in thin film design: Niche-like wrinkles designed for i-cell progenitor cell differentiation
  75. Respiratory syncytial virus infection influences tight junction integrity
  76. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients
  77. Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects
  78. Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort
  79. Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort
  80. Connexin43 Controls the Myofibroblastic Differentiation of Bronchial Fibroblasts from Patients with Asthma
  81. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
  82. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331
  83. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
  84. Cocaine Administration and Its Withdrawal Enhance the Expression of Genes Encoding Histone-Modifying Enzymes and Histone Acetylation in the Rat Prefrontal Cortex
  85. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis
  86. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
  87. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients
  88. Urinary prostanoids in preschool wheeze
  89. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies
  90. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production
  91. Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology
  92. The genetic evidence for human origin of Jivaroan shrunken heads in collections from the Polish museums
  93. Effect of DHA/EPA supplementation on endothelial damage markers. The bioclaims study
  94. Urinary 11‐Dehydro‐Thromboxane B 2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
  95. Pentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition
  96. Wrinkle-like structures in reconstructing stem cell niches
  97. Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab
  98. Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease
  99. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease
  100. Nanostructural haemocompatible coatings for the internal side of artificial blood vessels
  101. Silver nanoparticles influence on the blood activation process and their release to blood plasma from synthetic polymer scaffold
  102. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
  103. Lesions in the wingless gene of the Apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings, coming from the isolated population in Pieniny (Poland)
  104. Prostaglandin E2in Induced Sputum Following Oralaspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity
  105. Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?
  106. Physicochemical and Biological Investigation of Different Structures of Carbon Coatings Deposited onto Polyurethane
  107. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease
  108. Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma
  109. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier
  110. A lack of Wolbachia-specific DNA in samples from apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings
  111. Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
  112. The first U-BIOPRED sputum handprint of severe asthma
  113. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics
  114. Mortality in end‑stage renal disease: the importance of the genetic background
  115. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema
  116. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia
  117. Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis
  118. T-cell regulation during viral and nonviral asthma exacerbations
  119. Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis
  120. In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  121. Computer engineering in designing and fabrication of tissue analogue-type coating dedicated for the cardiovascular regeneration
  122. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells
  123. Erratum to: A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  124. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency
  125. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients
  126. Unravelling adverse reactions to NSAIDs using systems biology
  127. Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts
  128. Lack of association ofALOX12andALOX15Bpolymorphisms with psoriasis despite altered urinary excretion of 12(S)-hydroxyeicosatetraenoic acid
  129. S65 Urinary Prostaglandins As Inflammatory Markers For Childhood Asthma Exacerbations
  130. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
  131. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
  132. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity
  133. Graphene based porous coatings with antibacterial and antithrombogenous function—Materials and design
  134. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland
  135. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children
  136. AB0029 Imbalance between Immunoregulatory and Effector TH17 Pathway in Active Sle
  137. THU0498 Increase of CXCR3-CCR4+CCR6+CCR10- Memory T Helper Cells (TH17-LIKE) in Patients with Granulomatosis and Polyangiitis (GPA)
  138. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  139. Th2-type cytokine induced mucous metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection
  140. Carbon in airway macrophages from children with asthma
  141. Risk factors for arterial thrombosis in antiphospholipid syndrome
  142. Phagocytosis of fossil fuel particulates by macrophages in children with asthma
  143. Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells
  144. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs
  145. Grubość kompleksu błona wewnętrzna – błona środkowa tętnicy szyjnej koreluje z cechami zespołu metabolicznego u osób młodych z kliniczną diagnozą rodzinnej hipercholesterolemii
  146. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener’s) patients
  147. Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs
  148. Mutations of microsatellite autosomal loci in paternity investigations of the Southern Poland population
  149. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs
  150. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients
  151. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations
  152. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4
  153. Transforming growth factor-β1‑induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients
  154. Exhaled eicosanoid profiles in children with atopic asthma and healthy controls
  155. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients
  156. Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much more: Figure 1–
  157. Biographical memoir: Andrew Szczeklik 29 June 1938–3 February 2012
  158. CCR4-active chemokines contribute to blood and tissue eosinophilia in Churg–Strauss syndrome
  159. Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers
  160. The unfinished history of aspirin hypersensitivity – in memory of Professor Andrew Szczeklik
  161. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome
  162. Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
  163. Nasal Inflammatory Mediators In Non-steroidal Anti-inflammatory Drugs (nsaids) Cross-intolerant Subjects After Lysine Nasal Challenge
  164. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus
  165. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
  166. The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
  167. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  168. Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell–cell contacts
  169. Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration
  170. 832 INTIMA-MEDIA THICKNESS CORRELATES WITH FEATURES OF METABOLIC SYNDROME IN YOUNG PERSONS WITH CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
  171. 592 MUTATION SPECTRUM IN THE LDL RECEPTOR GENE IN PATIENTS FROM THE SOUTH-EASTERN PART OF POLAND
  172. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype
  173. Functional cardio-biomaterials
  174. Coxibs strike back
  175. Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation
  176. Eoxins: A new inflammatory pathway in childhood asthma
  177. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery
  178. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects
  179. Glucocorticoid receptor isoforms in steroid‑dependent asthma
  180. MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATION
  181. Elevated urinary leukotriene E4excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA
  182. Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease
  183. Assessment of hemocompatibility of materials with arterial blood flow by platelet functional tests
  184. Interaction of functionalFCER2promoter polymorphism and phenotype-associated haplotypes
  185. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome
  186. Genetic associations of variants of the high affinity receptor for immunoglobulin E in Wegener’s granulomatosis
  187. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years
  188. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease
  189. Single-stranded conformation polymorphism (SSCP)-driven indirect sequencing in detection of short deletion
  190. Genetic variability of the high-affinity IgE receptor α-subunit (FcεRIα)
  191. FCER1Agene proximal promoter polymorphisms in Caucasians and East Asians
  192. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma
  193. Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome
  194. Two Different Transcription Factors Discriminate the −315C>T Polymorphism of the FcεRIα Gene: Binding of Sp1 to −315C and of a High Mobility Group-Related Molecule to −315T
  195. The Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma
  196. FCER1A gene exon 1A polymorphisms in Japanese and Polish subjects – a comparative analysis of haplotypes
  197. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity
  198. The prevalence of alpha1-antitrypsin deficiency in a representative population sample from Poland
  199. Molecular diagnostics of α1-antitrypsin deficiency
  200. Coding region for the high affinity receptor of immunoglobulin E is highly conservative in allergic patients
  201. Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels
  202. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin
  203. FCERIA gene promoter polymorphisms: Lack of association with aspirin hypersensitivity in whites
  204. GENETIC POLYMORPHISMS OF THE NOVEL FCER1A GENE REGION: RELATION TO TOTAL SERUM IgE LEVELS
  205. Rapid and Inexpensive Detection of α1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening
  206. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease
  207. Genetic Variability of the High-affinity IgE Receptor α Subunit (Fc ε RI α) is Related to Total Serum IgE levels in Allergic Subjects
  208. Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management
  209. NOVEL EXON 2A OF THE HIGH-AFFINITY RECEPTOR FOR THE IgE α-CHAIN GENE (FCER1A) AND AUTOIMMUNITY IN PATIENTS WITH ASTHMA OR URTICARIA
  210. Towards a Multidisciplinary and Integrated Strategy in the Assessment of Adverse Health Effects Related to Air Pollution: The Case Study of Cracow (Poland) and Asthma
  211. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria
  212. The α-chain of high-affinity receptor for IgE (FcɛRIα) gene polymorphisms and serum IgE levels
  213. Towards a multidisciplinary and integrated strategy in the assessment of adverse health effects related to air pollution: The case study of Cracow (Poland) and asthma
  214. Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies
  215. The broken balance in aspirin hypersensitivity
  216. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant
  217. Rhinovirus Infection in Lower Airways of Asthmatic Patients
  218. Reactive Oxygen Species Metabolism and Allergy
  219. Anti-thrombotic action of clopidogrel and PlA1/A2polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin
  220. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism
  221. Aspirin resistance
  222. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma
  223. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib
  224. The dopamine D4 receptor VNTR in Polish schizophrenia patients
  225. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
  226. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
  227. Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
  228. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression
  229. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma
  230. Aspirin intolerance and the cyclooxygenase???leukotriene pathways
  231. X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A "European Community Alport Syndrome Concerted Action" Study
  232. Aspirin and thrombinogenesis
  233. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma
  234. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
  235. 3P-0859 The accuracy of D-dimer testing in patients with venous thromboembolism disease
  236. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist
  237. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease
  238. Repeated imipramine and electroconvulsive shock increase α1A-adrenoceptor mRNA level in rat prefrontal cortex
  239. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors
  240. Montelukast for persistent asthma
  241. Serum interleukin-5 in aspirin-induced asthma
  242. Leukotriene C4 synthase polymorphism and aspirin-induced asthma
  243. Aspirin-induced rhinitis and asthma
  244. Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia
  245. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma
  246. Genetics of aspirin induced asthma
  247. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa
  248. Enhanced Expression of the Leukotriene C4Synthase Due to Overactive Transcription of an Allelic Variant Associated with Aspirin-Intolerant Asthma
  249. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics
  250. X-linked Alport Syndrome
  251. Frequency data on the loci vWA, FES/FPS, F13A01, TH01, TPOX and CSF1P0 in a population from South Poland
  252. Genetic Mechanisms in Aspirin-induced Asthma
  253. Molecular Studies in Osteogenesis Imperfecta (OI)
  254. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma
  255. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation
  256. Data on the loci LDLR, GYPA, HBGG, D7S8 and GC in a South Polish population
  257. Role of leukotrienes in aspirin-induced asthma
  258. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
  259. D1S80 VNTR locus genotypes in population of South Poland; meta-analysis pointer to genetic disequilibrium of human populations
  260. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
  261. Fine deletion mapping of the p22 region of the human X chromosome using a radiation-induced hybrid panel
  262. A gene for achondroplasia–hypochondroplasia maps to chromosome 4p
  263. Limnology Of Missouri Reservoirs: An Analysis of Regional Patterns
  264. Alport syndrome: a genetic study of 31 families
  265. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 collagen gene
  266. 165 MOLECULAR ANALYSIS OF PKU HAPLOTYPES IN THE POPULATION OF SOUTHERN POLAND
  267. 166 TIME-PLACE CLUSTERS ANALYSIS FOR SELECTED CONGENITAL MALFORMATION IN SOUTHERN POLAND
  268. Hypersensitivity to Aspirin and other NSAIDs